These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10171820)

  • 21. FDA "approval" of medical devices.
    Health Devices; 1999; 28(5-6):235. PubMed ID: 10412079
    [No Abstract]   [Full Text] [Related]  

  • 22. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health device legislation: an overview of the law and its impact on respiratory care.
    Bancroft ML; Steen JA
    Respir Care; 1978 Dec; 23(12):1179-84. PubMed ID: 10315033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical devices. Part I. A primer on medical device regulation.
    Drew G
    FDA Consum; 1986 May; 20(4):24-7. PubMed ID: 10311540
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
    Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Jul; 63(146):40673-7. PubMed ID: 10181520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroenterology and urology devices; reclassification of the extracorporeal shock wave lithotripter. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(154):48609-12. PubMed ID: 11067714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First FDA medical device regulations will affect development of many experimental contraceptives.
    Fam Plann Perspect; 1980; 12(4):212-3. PubMed ID: 7439345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safe and effective medical devices--everyone's responsibility.
    Franke KA
    Gastroenterol Nurs; 1992 Apr; 14(5):245-8. PubMed ID: 1581379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice.
    Fed Regist; 1985 Oct; 50(204):42866-7. PubMed ID: 10274027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical devices. Part II. The Medical Device Amendments 10 years after. Interview by William Rados.
    Villforth J
    FDA Consum; 1986 May; 20(4):28-32. PubMed ID: 10311541
    [No Abstract]   [Full Text] [Related]  

  • 35. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical devices; medical device reporting. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.
    Kramer DB; Mallis E; Zuckerman BD; Zimmerman BA; Maisel WH
    Am J Ther; 2010; 17(1):2-7. PubMed ID: 20038828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is FDA's medical device evaluation process overly complaisant to industry?
    Margolis RE
    Healthspan; 1992; 9(7):19-20. PubMed ID: 10121440
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.